Improving The Breast Cancer Care Delivery Model for Sex and Gender Minority Survivors, Intended for SGM Study

NCT06205394 | Completed

• 2 other identifiers: OSU-22123NCI-2023-00667
• Study Type: observational
• Target: 28
• Locations: 1 country
• Sites: 1

Brief Summary

This study evaluates Improving the Breast Cancer Care Delivery Model for Sex and Gender Minority (INTENDED for SGM) in identifying the patient, support person and provider barriers to quality care in SGM breast/chest cancer survivors.

Conditions

Breast Carcinoma

Outcome Measures

Primary Outcomes (2)

• Survivor participant feedback, opinions, and preferences for breast cancer care

  Data is verbally reported and collected in focus groups

  At completion of study up to 2 years

• Clinician participant reports of experiences, opinions, and knowledge of caring for LGBTQ+ people

  Data is verbally reported and collected in interviews

  At completion of study up to 2 years

Study Arms (2)

GROUP 1 (focus group)

Cancer survivors participate in a focus group on study.

Other: Non-Interventional Study

GROUP 2 (interview)

Breast cancer clinicians undergo a semi-structured interview on study.

Other: Non-Interventional Study

Interventions

Non-Interventional Study OTHER

Non-interventional study

GROUP 1 (focus group); GROUP 2 (interview)

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Breast cancer survivors that self-identify as a member of the sex and gender minority community or partner with an individual of the same sex or gender and breast oncology clinicians recruited through Ohio State University Comprehensive Cancer Center.

You may qualify if:

• SURVIVORS:
• Self-identify as a member of the sex and gender minority community or partner with an individual of the same sex or gender
• Must be a breast cancer survivor, in active treatment or completed active treatment in the last 10 years (not including hormone therapy)
• Be over age 18
• English-speaking
• Received care in the US
• BREAST ONCOLOGY CLINICIANS: Physicians, advanced practice providers, nurses, psychologists and social workers will be eligible if they:
• Provide care and/or surgical decision support to individuals diagnosed with early stage breast cancer in the US
• Are English-speaking

Sponsors & Collaborators

• Ohio State University Comprehensive Cancer Center: lead

Study Sites (1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

Location

Related Links

• The Jamesline

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Elizabeth K Arthur, PhD

  Ohio State University Comprehensive Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: October 31, 2023
• First Posted: January 16, 2024
• Study Start: August 24, 2022
• Primary Completion: October 15, 2023
• Study Completion: October 15, 2023
• Last Updated: January 16, 2024

Record last verified: 2024-01

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)